Non classifié(e) 2 Minutes Laborie Publishes 2025 Sustainability Report Global medical technology company Laborie has published its 2025 Sustainability... Écrit par Laborie
Non classifié(e) 4 Minutes Laborie Announces First Procedures in ENDURE 1 Study with the Optilume® Ureteric Drug-Coated Balloon Landmark procedures launch the ENDURE 1 clinical study evaluating Optilume’s... Écrit par Laborie
Non classifié(e) 3 Minutes Laborie Appoints Chris Smith as Chief Executive Officer Laborie Medical Technologies Corp., a global leader in medical technology,... Écrit par Laborie
Non classifié(e) | Urologie et urogynécologie 3 Minutes Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association Laborie Medical Technologies Corp (Laborie), announced today that the American... Écrit par Laborie
Non classifié(e) 4 Minutes Laborie Medical Technologies Invests in Medical Technology Start-Up Bright Uro Laborie Medical Technologies announced a strategic equity investment in Bright... Écrit par Laborie
Non classifié(e) | Urologie et urogynécologie 5 Minutes Laborie Medical Technologies Acquires Urotronic Urotronic joins Laborie as part of a long-term growth strategy... Écrit par Laborie
Non classifié(e) | Urologie et urogynécologie 5 Minutes Laborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million Acquisition expands urology portfolio and demonstrates Laborie’s commitment to providing... Écrit par Laborie
Non classifié(e) 4 Minutes Laborie Transitions Urology and Gastroenterology Sales Model in Australia Écrit par Laborie
Non classifié(e) 6 Minutes Laborie’s Optilume® Technology Receives UK NICE Guideline Recommendations Écrit par mburgers
